🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementNausea incidence by dose tier — 6 month update Page 2

Nausea incidence by dose tier — 6 month update

Dr.LeslieOBGYN Thu, Aug 7, 2025 at 3:48 PM 12 replies 1,370 viewsPage 2 of 3
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Aug 8, 2025 at 7:25 AM#6
Dr.LipidDallas said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

Last edited: Aug 8, 2025 at 11:25 AM
15 10Dr.AddMedPHL, newstart_MO, mia_MS2 and 12 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Aug 8, 2025 at 1:36 PM#7

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Aug 8, 2025 at 5:36 PM
14 9mike.trainer_LA, sarah_nash92, FitDadDave and 11 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Aug 8, 2025 at 7:47 PM#8
mike.trainer_LA said:
I dislike how confidently this board tells people to push through.

Coming at mike.trainer_LA’s question from a different direction. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Last edited: Aug 8, 2025 at 11:47 PM
13 8LarryQC_SD, wanda_boise, NurseAsh_DET and 10 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
Aug 9, 2025 at 1:58 AM#9

Following on from Dr.AddMedPHL — and this may be the naive question:

What distinguishes the nausea you can titrate through from the nausea that means stop?

12 7CanadaChris, ZaraB_AL, JakeSmashed95 and 9 others
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Aug 10, 2025 at 7:41 AM#10

Reporting back.

Update. It was not the dose, it was that I had stopped drinking anything because drinking made me feel full. Fixing that fixed most of it.

4 2mike_mealprep, NicoleRaleigh, james_edin and 1 other
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register